A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea

A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium

NCT00001081 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals

NCT00002087 ·Status: COMPLETED ·Phase: PHASE1

A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea

NCT00001018 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea

NCT01374490 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea

NCT00547898 ·Status: COMPLETED ·Phase: PHASE3

A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis

NCT00002191 ·Status: COMPLETED ·Phase: PHASE3

A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons

NCT00000743 ·Status: COMPLETED ·Phase: PHASE1

Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study

NCT00002082 ·Status: COMPLETED ·Phase: NA

A Study of DPC 817 in HIV-Infected Males

NCT00040274 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients

NCT00390780 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

NCT00046332 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

NCT00002429 ·Status: COMPLETED ·Phase: PHASE3

A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3

NCT00002106 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors

NCT00007449 ·Status: UNKNOWN ·Phase: PHASE2

A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

NCT00000823 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Patients Who Have Not Had Success With Zidovudine

NCT00001025 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease

NCT00002244 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of Z-100 in Patients With Early HIV Infection

NCT00016692 ·Status: TERMINATED ·Phase: PHASE1

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

NCT00082498 ·Status: COMPLETED ·Phase: PHASE2

Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults

NCT00708110 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis

NCT00002158 ·Status: UNKNOWN ·Phase: NA

Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients

NCT00002099 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts

NCT00000908 ·Status: COMPLETED

A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients

NCT00000991 ·Status: COMPLETED ·Phase: PHASE3

Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine

NCT00002035 ·Status: COMPLETED ·Phase: NA